Events

American Society of Hematology

-

Denver, Colorado, USA

Involvement

Presentation on - EXACT: LLMs for Structured Eligibility Extraction for Clinical Trial Matching

The AMIA Amplify Informatics Conference brings together clinical and translational informatics professionals for four days of insight, collaboration, and innovation. Taking place 18–21 May 2026 in Denver, CO, the event unites science, practice, and policy to advance the future of healthcare informatics. CancerBot is proud to be speaking at this year's conference.

American Society of Hematology

-

Harvard University

Involvement

Presentation on the architecture of our EXACT clinical trial matcher.

Patient-Powered Progress is a three-day program dedicated to advancing real-world, patient-centered innovation. This series of events brings together healthcare leaders, technology innovators, researchers, patient advocates, and industry partners to explore how AI and emerging digital tools can improve engagement, education, and outcomes. The conference proceedings will be published online by IOS Press and PubMed-indexed.

The goal of Patient-Powered Progress 2026 is to bring together people and organizations committed to solving the next generation of real-world, patient-centered challenges. This conference is designed not just to showcase innovation, but to spark new collaborations across healthcare, pharma, payers, patient advocacy groups, and technology partners—creating shared momentum around solutions that matter to patients and the systems that support them.

Through presentations, posters, case studies, panels, and hands-on workshops, we aim to identify common problems, build multi-stakeholder projects that can scale, and advance both practical impact and academic knowledge. Participants will help shape the future direction of the DCI Network by surfacing new patient-facing initiatives that can extend beyond current chatbot work and become long-term, sustainable pillars for the consortium.

Participants will work together to identify high-value patient challenges, develop collaborative solutions that span multiple sectors, and strengthen the growing DCI Network community. Our focus is on building relationships, accelerating scalable projects, and shaping both the practical and academic impact of patient-centered AI.

American Society of Hematology

-

Liverpool Experience Campus (LEX)

Involvement

Presenting a paper on accuracy with Multiple Myeloma.

The British Society for Haematology's 66th Annual Scientific Meeting will deliver a programme that reflects the breadth of modern haematology, from core practice to emerging science. It is designed to be relevant and engaging for haematologists, scientists, nurses, and professionals across all sub-specialities within the field.

American Society of Hematology

-

Stockholm, Sweden

Involvement

Presentation on best practices in clinical trial matching.

EHA2026 Congress - Stay at the forefront of hematology

EHA2026 will offer an exceptional scientific program, featuring a seamless flow of engagement across Plenary Sessions—including the Opening Ceremony, Plenary Abstracts Session, and Presidential Sessions—alongside carefully curated Sponsor Symposiums spread throughout each Congress day.

About CancerBot

Turning frustration into innovation

After being diagnosed with follicular lymphoma, AI tech entrepreneur Adam Blum assumed he could easily find cutting-edge treatment options. Instead, he faced resistance from doctors and an exhausting search process. Determined to fix this, he built CancerBot—an AI-powered tool that makes clinical trials more accessible, helping patients find potential life-saving treatments faster.

About CancerBot

Turning frustration into innovation

After being diagnosed with follicular lymphoma, AI tech entrepreneur Adam Blum assumed he could easily find cutting-edge treatment options. Instead, he faced resistance from doctors and an exhausting search process. Determined to fix this, he built CancerBot—an AI-powered tool that makes clinical trials more accessible, helping patients find potential life-saving treatments faster.

About CancerBot

Turning frustration into innovation

After being diagnosed with follicular lymphoma, AI tech entrepreneur Adam Blum assumed he could easily find cutting-edge treatment options. Instead, he faced resistance from doctors and an exhausting search process. Determined to fix this, he built CancerBot—an AI-powered tool that makes clinical trials more accessible, helping patients find potential life-saving treatments faster.

Start your AI-powered clinical trial search

New treatment options could be just a click away. Start a chat with CancerBot today and get matched with clinical trials tailored to you—quickly, easily, and at no cost.

Start your AI-powered clinical trial search

New treatment options could be just a click away. Start a chat with CancerBot today and get matched with clinical trials tailored to you—quickly, easily, and at no cost.

Start your AI-powered clinical trial search

New treatment options could be just a click away. Start a chat with CancerBot today and get matched with clinical trials tailored to you—quickly, easily, and at no cost.